PropTech entity
commercial-real-estate is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Bank of America, the most common co-covered peer. The tracked stories average 2 original sources each. Teva Pharmaceutical Industries appears in 1 tracked PropTech story from August 5, 2026.
Last mentioned: Aug 5, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
commercial-real-estate is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Bank of America, the most common co-covered peer. The tracked stories average 2 original sources each. Teva Pharmaceutical Industries appears in 1 tracked PropTech story from August 5, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 8 PropTech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Teva Pharmaceutical Industries. Shared-story counts are live from our verified record — not editorial picks.
CBRE Group's above-consensus EPS guidance underscores the commercial real estate sector's momentum, driven by technology-driven services. For PropTech startups and investors, it signals growing client spending on smart buildings, data analytics, and digital brokerage platforms.
Teva Pharmaceutical Industries is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
